To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Retrieved from the GovBot source 9/23/2026, 10:18:54 PM (UTC). Viewing this record does not change stored data.
At a glance
- Bill number
- HR 1492
- Status
- Not provided
- Latest recorded action
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
Not provided in this source record.
Recorded activity
Newest date first. Actions with the same timestamp retain source order.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Retrieval & source record
- Search index built (UTC)
- 2026-09-07T10:23:11.520Z
- Dataset
- govbot-data/usa-legislation
- Retrieved (UTC)
- 2026-09-23T22:18:54.751Z
- Live source branch
- main (mutable; checksum identifies the retrieved record)
- Search index revision
b5b4a6d28d2dd595bb5724470458ffceaf19bcb7- Original record
- View GovBot metadata JSON (opens in a new tab)
- Record SHA-256
a76050ae638b1c94a664ff3856bbd50f05a0577676a5246ca35be6c61e250aed